ID   CESS
AC   CVCL_0209
SY   Cess
DR   BTO; BTO:0004327
DR   CLO; CLO_0002360
DR   EFO; EFO_0002130
DR   MCCL; MCC:0000098
DR   CLDB; cl695
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; TIB-190
DR   BioSample; SAMN03471942
DR   cancercelllines; CVCL_0209
DR   Cell_Model_Passport; SIDM00917
DR   ChEMBL-Cells; CHEMBL3308863
DR   ChEMBL-Targets; CHEMBL2366361
DR   CLS; 300262
DR   Cosmic; 683658
DR   Cosmic; 910688
DR   Cosmic; 2131534
DR   Cosmic; 2306201
DR   Cosmic-CLP; 910688
DR   DepMap; ACH-002218
DR   ECACC; 92110206
DR   EGA; EGAS00001000978
DR   GDSC; 910688
DR   GEO; GSM1669671
DR   IARC_TP53; 21221
DR   IGRhCellID; CESS
DR   LINCS_LDP; LCL-1050
DR   PharmacoDB; CESS_192_2019
DR   Progenetix; CVCL_0209
DR   PubChem_Cell_line; CVCL_0209
DR   Wikidata; Q54809343
RX   PubMed=3106068;
RX   PubMed=6972960;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=CESS
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Genome ancestry: African=6.92%; Native American=0.8%; East Asian, North=5.8%; East Asian, South=0%; South Asian=5.27%; European, North=21.66%; European, South=59.54% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (ATCC; CLS; ECACC)
ST   CSF1PO: 10,11,12 (Cosmic-CLP)
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,16
ST   D21S11: 27,30
ST   D3S1358: 15,18
ST   D5S818: 10,11,12,13 (Cosmic-CLP)
ST   D5S818: 11,12 (ATCC; CLS; ECACC)
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16,17,18 (Cosmic-CLP)
ST   vWA: 16,17 (ATCC; CLS; ECACC)
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 33
//
RX   PubMed=3106068; DOI=10.1002/eji.1830170416;
RA   Shields J.G., Smith S.H., Levinsky R.J., DeFrance T., de Vries J.E.,
RA   Banchereau J., Callard R.E.;
RT   "The response of selected human B cell lines to B cell growth and
RT   differentiation factors.";
RL   Eur. J. Immunol. 17:535-540(1987).
//
RX   PubMed=6972960; DOI=10.4049/jimmunol.127.2.412;
RA   Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaieda T.,
RA   Yoshizaki K., Yamamura Y.;
RT   "T cell-replacing factor- (TRF) induced IgG secretion in a human B
RT   blastoid cell line and demonstration of acceptors for TRF.";
RL   J. Immunol. 127:412-416(1981).
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S.,
RA   Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P.,
RA   Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H.,
RA   Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//